SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 1,076,750 shares at $6.05 ($6.4M) on 2025-10-08, disclosed to the SEC on 2025-10-09.
Scheduled sale ($6.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 72,133 | $404K | 6.3% |
| 2 | $5.60 | 72,133 | $404K | 6.3% |
| 3 | $6.05 | 466,242 | $2.8M | 43.7% |
| 4 | $6.05 | 466,242 | $2.8M | 43.7% |
| Total | $5.99 avg | 1,076,750 | $6.4M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |
| CPNG | SELL | 2025-05-12 | $772.5M | — | Filing → |